Clinical Study
Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
Table 1
Mortality risk factors: comparison between nonsurvivor and survivor groups.
| | Nonsurvivors
| Survivors
| value |
| Number of positive fungal cultures, mean | 5.0 | 2.6 | 0.001 | Platelet count nadir during IFI: 1000 cells/mm3, mean | 38 | 73 | 0.01 | NICU stay at time of first positive fungal culture (mean, days) | 69.5 | 32.8 | 0.004 | Postconceptional age at time of positive culture (mean, weeks) | 35.1 | 40.5 | 0.03 | Gestational Age | | | | ββ€26 | 10 | 19 | | β27β32 | 1 | 6 | | β33β37 | 6 | 5 | | Term | 5 | 11 | | Gender | | | | βMale | 13 | 17 | | βFemale | 9 | 24 | | Congenital heart disease | | | | βYes | 5 | 10 | | βNo | 17 | 31 | | Age (days) at time of first positive fungal culture | | | | ββ€14 | 4 | 14 | | β15β28 | 4 | 10 | | β29β60 | 4 | 12 | | β61β120 | 6 | 4 | | β>120 | 4 | 1 | | Time on mechanical ventilation before first positive fungal culture (mean, days) | 46.0 | 21.6 | 0.002 | Time with CVC before first positive fungal culture (mean, days) | 60.1 | 31.1 | 0.001 | Time with urinary catheter before first positive fungal culture (mean, days) | 7.5 | 14.4 | 0.06 | Time between first positive culture and initiation of therapy (median, days) | 4 | 2 | 0.001 |
|
|